- Trang Chủ
- Y khoa - Dược
- Clinical outcomes of advanced non-small cell lung cancer patients harboring distinct subtypes of EGFR mutations and receiving first line tyrosine kinase inhibitors: Brain metastasis and de novo T790M matters
Xem mẫu
nguon tai.lieu . vn